Confusion clinical trials
The registry lists 88 studies for Confusion across more than 10 countries. 19 are recruiting or about to start. 20 of them are mainly about Confusion (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 2 narrower conditions too, such as Delirium: 1,620 studies, 435 open.
Get an email when these change. Save the Confusion studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
UMC Utrecht (3) · University Hospital, Clermont-Ferrand (3) · Celgene (2) · Duke University (2) · University Medical Center Rostock (2) · Indiana University (2) · Johns Hopkins University (2) · University of Chile (2)
What is being tested here
Drugs under test in Confusion studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Dexmedetomidine | 1 | 1 | 2 |
| Lorazepam | 1 | 0 | 1 |
| Tianeptine | 1 | 0 | 1 |
| Ketamine | 0 | 0 | 2 |
| Haloperidol | 0 | 0 | 2 |
| Canagliflozin | 0 | 1 | 1 |
| Sitagliptin | 0 | 1 | 1 |
| Melatonin | 0 | 0 | 1 |
| Hesperidin | 0 | 0 | 1 |
| Bupivacaine | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 6
- Dec 2026Pervasive Sensing and AI in Intelligent ICU · University of Florida
- Dec 2026Using Virtual Reality to Improve Medical Training · Ohio University
- Mar 2027Triple Sleep-promotion Protocol for Delirium Prevention in Intensive Care Patients · Naile ALANKAYA
- Apr 2027Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19. · Military Institute od Medicine National Research Institute
- Jun 2027Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial · Universitat de Lleida
- Sep 2027Multi-Component Delirium Prevention Bundle in Older Cardiac Intensive Care Unit Patients · Tel Aviv Medical Center
Who these studies take
Of the 11 Confusion studies recruiting now, 10 (91%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (9%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 8 (73%) | 8 (73%) |
| 30 | 8 (73%) | 8 (73%) |
| 40 | 8 (73%) | 8 (73%) |
| 50 | 8 (73%) | 8 (73%) |
| 65 | 10 (91%) | 10 (91%) |
| 75 | 11 (100%) | 11 (100%) |
| 85 | 11 (100%) | 11 (100%) |
Across all 88 studies, recruiting or not: 13% stop at 75 or younger and 10% at 65; 3% take children; 0% are for women only and 1% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Confusion studies take
Of 20 interventional studies with no phase under Confusion, half reached primary completion within 32 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 32 mo18–41 · 20 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 12, 2026.
Stopped1
- Phenobarbital for Agitated DeliriumWithdrawnNov 6, 2026NCT07548489
Studies
Recruiting first, then most recently updated. Showing 50 of 88. Browse all 88 → or search them.
- Patients With Long-stay at ICU: Factors and Evaluation - Feasibility StudyNot yet recruitingNCT078519741 country
- Triple Sleep-promotion Protocol for Delirium Prevention in Intensive Care PatientsRecruitingNCT07801092Not applicable1 country
- Exploring the Effectiveness of Intelligent Audiovisual Interventions in Delirium, Agitation, and Pain Among Middle Aged and Elderly Patients in Emergency Intensive Care Units: A Quasi-Experimental StudyNot yet recruitingNCT07776002Not applicable
- ICU Delirium Playbook Training Study for ICU NursesRecruitingNCT07759310Not applicable1 country
- Pervasive Sensing and AI in Intelligent ICURecruitingNCT051272651 country
- Effects of Different Types of Music Therapy Combined With Mindful Breathing on Delirium, Pain, and Anxiety in ICU PatientsNot yet recruitingNCT07624097Not applicable
- Using Virtual Reality to Improve Medical TrainingRecruitingNCT07542834Not applicable1 country
- Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-IndexNot yet recruitingNCT07428681Phase 4
- Researching Efficient Approaches to Delirium Identification-Sustaining Effective TranslationRecruitingNCT05915377Not applicable1 country
- Delirium and Heart FailureNot yet recruitingNCT073027371 country
- Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized TrialNot yet recruitingNCT07293078Phase 1/21 country
- Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery PatientsRecruitingNCT04289142Phase 41 country
- Clinical Trial Protocol: Alzheimer's Dementia Underlying EncephalopathyRecruitingNCT07222280Not applicable1 country
- VoiceLove Digital Therapy for Delirium in the ICURecruitingNCT07218484Not applicable1 country
- Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled TrialNot yet recruitingNCT06809894Not applicable1 country
- Evaluation of Safe Use of SECURIDRAP® SELFIA®RecruitingNCT05510401Not applicable1 country
- Occupational Therapy Intervention on the Prevention of Delirium and Occupational Performance Status in Elderly PatientsNot yet recruitingNCT06479031Not applicable
- Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.RecruitingNCT06012552Phase 21 country
- Braindex Cerebral Tissue Oxygen Saturation (SctO2) Measurement Algorithm Assessment and ImprovementRecruitingNCT05897060Not applicable1 country
- Phenobarbital for Agitated DeliriumWithdrawnNCT07548489Phase 31 country
- Multi-Component Delirium Prevention Bundle in Older Cardiac Intensive Care Unit PatientsActive, not recruitingNCT07776184Not applicable1 country
- Intelligent Intensive Care UnitActive, not recruitingNCT024653071 country
- Nutritional Management of Post COVID-19 Cognitive SymptomsActive, not recruitingNCT05705648Not applicable1 country
- Physical Restraints in Intensive Care Unit PatientsCompletedNCT04957238Not applicable1 country
- Trazodone vs. Quetiapine for the Treatment of ICU DeliriumTerminatedNCT053070031 country
- Atropine Weight and Risk of Postoperative Confusion in the ElderlyCompletedNCT033907511 country
- Sight and Hearing Investigation Into Effects on DeliriumCompletedNCT061766251 country
- Validation of a French Version of the Confusion Assessment Method (CAM)CompletedNCT017759821 country
- Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CompletedNCT030985891 country
- Preoperative Prognostic Nutritional Index and Postoperative Delirium in Gastrointestinal Cancer SurgeryCompletedNCT066031291 country
- Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)CompletedNCT04304261Phase 31 country
- Cognitive Functions After TIVA With DexmedetomidineCompletedNCT02631135Phase 41 country
- Music Therapy as a Treatment for Delirium in Acutely Hospitalized Older PatientsCompletedNCT05398211Not applicable1 country
- Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)CompletedNCT04007523Not applicable1 country
- Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences)CompletedNCT043629301 country
- Neuronal Damage In Delirium StudyCompletedNCT037242011 country
- Analysis of Parameters Indicating the Intensity of Suicidal Behavior in Psychiatric PatientsCompletedNCT05803447
- Clinical Evaluation Program of DeltaScan (ICU)TerminatedNCT03735940Not applicable1 country
- Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable1 country
- A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mgCompletedNCT029218282 countries
- Clinical Evaluation Program of DeltaScan (Ward)TerminatedNCT03735927Not applicable1 country
- Study of Melatonin on Sleep, Pain, and Confusion After Joint Replacement SurgeryCompletedNCT01505465Not applicable1 country
- Abbott Brady 3T MRI PMCFCompletedNCT037866405 countries
- Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)CompletedNCT04715932Phase 21 country
- Family Automated Voice Reorientation StudyCompletedNCT03128671Not applicable1 country
- Efficiency of the Imaging Strategy for the Management of Suspected Covid-19CompletedNCT050772281 country
- A Software to Prevent Delirium (PREVEDEL) in Hospitalized Older AdultsStatus unknownNCT05108207Not applicable1 country
- Cognitive Recovery After Electroconvulsive Therapy and General AnesthesiaCompletedNCT02761330Not applicable1 country
- INcidence of PostOperative Delirium Incidence in Surgical Patients: an Observational Cohort Study in New ZealandStatus unknownNCT048403161 country
- Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated VertigoSuspendedNCT03886012Not applicable1 country